Xian Yu

Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease

Fasiha Kanwal, Jennifer R. Kramer, Liang Li et al. · Hepatology · 2019 · 314 citations

Medicine, Oncology, Cancer Epidemiology +15

GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

Fasiha Kanwal, Jennifer R. Kramer, Liang Li et al. · JAMA Internal Medicine · 2024 · 126 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease

Jennifer R. Kramer, Yamini Natarajan, Jianliang Dai et al. · Hepatology · 2021 · 112 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease

George Cholankeril, Jennifer R. Kramer, Jinna Chu et al. · Journal of Hepatology · 2022 · 108 citations · Full text

Medicine, Internal Medicine, Pathology +15

Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes

Yamini Natarajan, Jennifer R. Kramer, Xian Yu et al. · Hepatology · 2020 · 71 citations · Full text

Medicine, Internal Medicine, Oncology +17